WebbSignificance Statement The α7-type nicotinic acetylcholine receptor (nAChR) is acknowledged as a potentially important therapeutic target with functional properties … WebbTherapeutic strategies Cancer Small-molecule inhibitors MYC protein interactors Introduction The oncoprotein MYC is a pleiotropic transcription factor that modulates global gene expression and regulates critical cellular processes including proliferation, differentiation, cell cycle, metabolism and apoptosis.
Therapeutic targeting of preleukemia cells in a mouse model of
Webb7 apr. 2024 · Therapeutic resistance can be conferred by genetic alterations or dynamic adaptation of cell signaling pathways. Because potent pro-apoptotic signals are known to be activated in response to MEK suppression, we investigated whether direct changes in pro-survival proteins might mediate resistance to these agents in PDACs. Webb11 apr. 2024 · Abzu® and Contera Pharma expand their strategic partnership to add drug-target identification to their seminal RNA- and siRNAs therapeutic design platform. Contera Pharma is a Danish biotech company -developing innovative small-molecule and RNA-based therapeutics to address neurological disorders. Their unique R&D model … eagle fulfillment bowling green ky
Novel endocrine therapeutic strategy in endometrial carcinoma …
WebbNovel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor alpha by XCT790 and siRNA PengMing Sun,1,* XiaoDan Mao,1,* Min Gao,2 MeiMei ... JS, Kunder R, Zuercher WJ, McDonnell DP. The metabolic regulator ERRalpha, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer. Cancer Cell ... WebbThe present specification discloses a novel use of granulocyte colony-stimulating factor receptor or colony-stimulating factor 3 receptor (CSF3R) as a biomarker and as a therapeutic target for pulmonary fibrosis. The present specification discloses a treatment mechanism, a treatment method, and a treatment drug involving CSF3R for pulmonary … Webb6 feb. 2024 · To improve the success of myeloid cell-targeted therapies, it will be important to target tumour types and patient subsets in which myeloid cells represent the … eagle fundraising application